BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Valenti MT, Dalle Carbonare L, Mottes M. Ectopic expression of the osteogenic master gene RUNX2 in melanoma Maria Teresa Valenti, Luca Dalle Carbonare, Monica Mottes. World J Stem Cells 2018; 10(7): 78-81 [PMID: 30079129 DOI: 10.4252/wjsc.v10.i7.78]
URL: https://www.wjgnet.com/1948-0210/full/v10/i7/78.htm
Number Citing Articles
1
Sundaramoorthy Revathidevi, Arasambattu Kannan Munirajan. Akt in cancer: Mediator and moreSeminars in Cancer Biology 2019; 59: 80 doi: 10.1016/j.semcancer.2019.06.002
2
Melinda Duer, Andrew M. Cobb, Catherine M. Shanahan. DNA Damage ResponseArteriosclerosis, Thrombosis, and Vascular Biology 2020; 40(7) doi: 10.1161/ATVBAHA.120.313792
3
Zuan Li, DeYong Nong, Bincai Li, Haojian Wang, Chunlin Li, Zhi Chen, Ximing Li, Guihai Huang, Junhao Lin, Nan Hao, Wei Li. Effect of AKT silence on malignant biological behavior of renal cell carcinoma cellsBMC Urology 2022; 22(1) doi: 10.1186/s12894-022-01087-4
4
Guangrun Li, Xiaofeng Jiang, Liping Liu, Xiaoyang Liu, Hongtao Liu, Zuofu Zhang. Effect of estradiol on high glucose‑induced osteoblast injuryMolecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.10552
5
Michela Deiana, Luca Dalle Carbonare, Michela Serena, Samuele Cheri, Simona Mutascio, Alberto Gandini, Giulio Innamorati, Pamela Lorenzi, Michela Cumerlato, Jessica Bertacco, Franco Antoniazzi, Maria Grazia Romanelli, Monica Mottes, Donato Zipeto, Maria Teresa Valenti. A Potential Role of RUNX2- RUNT Domain in Modulating the Expression of Genes Involved in Bone Metastases: An In Vitro Study with Melanoma CellsCells 2020; 9(3): 751 doi: 10.3390/cells9030751
6
Da-Ping Yang, Wan-Ying Huang, Gang Chen, Shang-Wei Chen, Jie Yang, Rong-Quan He, Su-Ning Huang, Ting-Qing Gan, Jie Ma, Lin-Jie Yang, Jian-Hua Song, Jun-Xian Mo, Zhong-Qing Tang, Chang-Bo Li, Hua-Fu Zhou, Jin-Liang Kong. Clinical significance of transcription factor RUNX2 in lung adenocarcinoma and its latent transcriptional regulating mechanismComputational Biology and Chemistry 2020; 89: 107383 doi: 10.1016/j.compbiolchem.2020.107383
7
Shuangshuang Shi, Haojie Chen, Hanqing Wang, JianFeng Wan, Yi Shi, Jia Li, Shuo Wang, Jie Shi, Jianying Lv, Tong Wu, Longlong Wang, Fengyuan Sun. Genome-wide CRISPR knockout screening identified G protein pathway suppressor 2 as a novel tumor suppressor for uveal melanoma metastasisJournal of Cancer Research and Clinical Oncology 2023; 149(7): 3349 doi: 10.1007/s00432-022-04160-5
8
Daniela Cecconi, Jessica Brandi, Marcello Manfredi, Michela Serena, Luca Dalle Carbonare, Michela Deiana, Samuele Cheri, Francesca Parolini, Alberto Gandini, Giulia Marchetto, Giulio Innamorati, Francesco Avanzi, Franco Antoniazzi, Emilio Marengo, Natascia Tiso, Monica Mottes, Donato Zipeto, Maria Teresa Valenti. Runx2 stimulates neoangiogenesis through the Runt domain in melanomaScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-44552-1
9
Gloria Manzotti, Federica Torricelli, Benedetta Donati, Valentina Sancisi, Mila Gugnoni, Alessia Ciarrocchi. HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanismsJournal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1350-5
10
Maria Teresa Valenti, Giulia Marchetto, Massimiliano Perduca, Natascia Tiso, Monica Mottes, Luca Dalle Carbonare. BEL β-Trefoil Reduces the Migration Ability of RUNX2 Expressing Melanoma Cells in Xenotransplanted ZebrafishMolecules 2020; 25(6): 1270 doi: 10.3390/molecules25061270
11
Juan Yang, Jianming Ye, Tengfei Ma, Fangfang Tang, Li Huang, Zhen Liu, Song Tian, Xu Cheng, Li Zhang, Zhenli Guo, Fuping Tu, Miao He, Xueming Xu, Xiaojuan Lu, Yanyang Wu, Xiaoli Zeng, Jiahua Zou, Xiangcai Wang, Weijie Peng, Peng Zhang. Tripartite motif‐containing protein 11 promotes hepatocellular carcinogenesis through ubiquitin‐proteasome–mediated degradation of pleckstrin homology domain leucine‐rich repeats protein phosphatase 1Hepatology 2022; 76(3): 612 doi: 10.1002/hep.32234
12
Weizhu Zhao, Haiying Yang, Jie Chai, Ligang Xing. RUNX2 as a promising therapeutic target for malignant tumorsCancer Management and Research 2021; : 2539 doi: 10.2147/CMAR.S302173